Shockwave Therapy for Erectile Dysfunction After Prostate Cancer Treatment

What is erectile dysfunction (ED)?

Erectile dysfunction (ED) is the inability to achieve or maintain an erection sufficient for satisfactory sexual performance. ED can stem from various causes, including issues with blood flow, nerve damage, or psychological factors. It’s a common condition, particularly in men over 40, and it can significantly affect quality of life.

How prevalent is ED after prostate cancer treatment?

ED is a common side effect of prostate cancer treatment.

• After radical prostatectomy (prostate removal surgery): Studies indicate that up to 60-90% of men may experience ED within the first year post-surgery, depending on factors such as age, pre-existing erectile function, and whether nerve-sparing techniques were used.
• After radiotherapy: ED rates following radiotherapy vary widely, with reports suggesting that 30-50% of men might develop ED within two years of treatment. The onset of ED after radiotherapy tends to be gradual, often appearing 1-2 years post-treatment.

What is shockwave therapy for treating impotence?

Low-Intensity Extracorporeal Shockwave Therapy (Li-ESWT) is a treatment that uses sound waves to enhance blood flow and stimulate nerve regeneration in the penis. Unlike other ED treatments that focus on managing symptoms, shockwave therapy aims to repair the underlying damage caused by prostate cancer treatments.

How does shockwave therapy improve erectile function?

Shockwave therapy promotes the following:

• Neo-vascularisation: The formation of new blood vessels, which improves blood flow to the penis.
• Nerve regeneration: Helps repair nerve damage that may have occurred during prostate cancer treatments.
• Reduction in fibrosis: Lowers the scarring in penile tissue that can result from surgery or radiotherapy, improving the tissue's elasticity and function.

What is an example of a shockwave therapy protocol?

A typical session of shockwave therapy might look like this:

1. Preparation: The patient lies on a treatment table. A topical anaesthetic gel may be applied to the penis to minimise discomfort.
2. Application: A device that emits low-intensity sound waves is placed on different parts of the penis. These sound waves are usually directed at multiple sites, including the penile shaft and the base of the penis (crura).
3. Session Duration: Each session typically lasts around 15-20 minutes, during which thousands of shockwaves are delivered. A common protocol might include 1-2 sessions per week for a total of 6-12 sessions, depending on the severity of the ED and the specific protocol used.
4. Post-Treatment: There is usually no downtime after the procedure, and patients can resume normal activities immediately. Some might experience mild redness or discomfort, but this is generally short-lived.

What are the expected outcomes from shockwave therapy?

Results can vary, but many patients report improvements in their ability to achieve and maintain erections after completing a course of shockwave therapy. The degree of improvement can depend on several factors, including:

• Severity of ED: Men with mild to moderate ED tend to see the most benefit.
• Timing of treatment: Early intervention post-surgery or radiotherapy might yield better results.
• Combination with other treatments: Using shockwave therapy in conjunction with oral medications like PDE5 inhibitors (e.g., Viagra) can enhance outcomes.

What should patients consider before starting shockwave therapy?

• Consult with a specialist: It's crucial to speak with a urologist who can evaluate your specific condition and determine whether shockwave therapy is suitable for you.
• Understand the limitations: While promising, shockwave therapy is not guaranteed to work for everyone. Being aware of potential outcomes helps set realistic expectations.
• Cost and availability: Shockwave therapy may not be covered by insurance, and out-of-pocket costs can be high. Additionally, not all medical centres offer this treatment.

Are there any side effects?

Most patients tolerate shockwave therapy well, with few side effects. Some men might experience mild discomfort or bruising at the treatment site, but these symptoms typically resolve quickly.

‍

What are the alternative treatments for ED after prostate cancer treatment?

If shockwave therapy isn't suitable or desired, there are several other treatments available for managing ED after prostate cancer treatment:

• Oral Medications: PDE5 inhibitors (such as Viagra, Cialis, and Levitra) are often the first line of treatment. They work by increasing blood flow to the penis to help achieve an erection.
• Vacuum Erection Devices (VEDs): These devices create a vacuum around the penis, drawing blood into it and causing an erection. A constriction ring is then placed at the base of the penis to maintain the erection.
• Penile Injections: Medications like alprostadil can be injected directly into the penis to stimulate an erection. This method is typically used when oral medications are not effective.
• Vitaros: Vitaros is a topical cream that contains alprostadil, similar to the injectable form. It is applied directly to the urethral opening and helps increase blood flow to the penis. Vitaros can be a good option for men who prefer a non-invasive treatment and those who do not respond well to oral medications.
• Intraurethral Suppositories: Alprostadil can also be administered via a small suppository placed in the urethra. This method is less invasive than injections but can be less effective.
• Penile Implants: For men who do not respond to other treatments, a surgical option involves the implantation of a device that allows the penis to become erect. This is typically considered when other treatments have failed.
• Counselling and Therapy: Since psychological factors can contribute to ED, counselling or sex therapy may be beneficial, especially in cases where anxiety, depression, or relationship issues are present.

‍

What does the future hold for shockwave therapy in ED treatment?

Researchers are investigating ways to optimise shockwave therapy, such as refining the energy levels and treatment frequencies to enhance efficacy. There is also interest in combining shockwave therapy with other regenerative treatments, like platelet-rich plasma (PRP) or stem cell therapy, to improve outcomes further.

With more research, particularly long-term studies, shockwave therapy has the potential to become a standard part of ED management post-prostate cancer treatment. However, more robust data is needed to solidify its role and determine the best protocols.

‍